Literature DB >> 22753796

A case of de novo seizures following a probable interaction of high-dose baclofen with alcohol.

Benjamin Rolland1, Sylvie Deheul, Thierry Danel, Régis Bordet, Olivier Cottencin.   

Abstract

AIMS: Baclofen is a promising medication for the treatment of alcohol dependence, and the prescription of high-dose baclofen (HDB) is increasing within the medical community, especially for patients who are unresponsive to approved treatments. Although baclofen is considered to be quite safe at low doses, the possible interactions between HDB and alcohol have not been precisely studied.
METHODS: We report the case of a 46-year-old patient without any history of neurological disorders who experienced two episodes of seizures after a short relapse of alcohol misuse while undergoing treatment with up to 240 mg/day of baclofen.
RESULTS: Although both alcohol and baclofen may theoretically induce seizures individually, we discuss and largely rule out the likelihood that either of these two drugs was solely responsible for the patient's seizures. We hypothesize that the seizures resulted from an interaction between alcohol and HDB, and determined that this hypothesis is 'probable' with Horn's Drug Interaction Probability Scale.
CONCLUSION: We encourage our colleagues who prescribe HDB to acquaint their patients with the possible enhanced risk of seizures, notably in persistence of alcohol abuse. Moreover, until data from a large study on the safety of HDB use by alcohol misusers are available, this treatment should be conducted under strict supervision and after having carefully evaluated the benefit-risk ratio.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22753796     DOI: 10.1093/alcalc/ags076

Source DB:  PubMed          Journal:  Alcohol Alcohol        ISSN: 0735-0414            Impact factor:   2.826


  7 in total

1.  Attitudes of community pharmacists to off-label prescribing of baclofen in Northern France.

Authors:  Marine Auffret; Benjamin Rolland; Anne-Sylvie Caous; Sylvie Deheul; Johana Béné; Olivier Cottencin; Régis Bordet; Sophie Gautier
Journal:  Int J Clin Pharm       Date:  2015-02-10

2.  Proactive Regional Pharmacovigilance System Versus National Spontaneous Reporting for Collecting Safety Data on Concerning Off-Label Prescribing Practices: An Example with Baclofen and Alcohol Dependence in France.

Authors:  Marine Auffret; Julien Labreuche; Alain Duhamel; Sylvie Deheul; Olivier Cottencin; Régis Bordet; Sophie Gautier; Benjamin Rolland
Journal:  Drug Saf       Date:  2017-03       Impact factor: 5.606

Review 3.  Baclofen therapeutics, toxicity, and withdrawal: A narrative review.

Authors:  Jia W Romito; Emily R Turner; John A Rosener; Landon Coldiron; Ashutosh Udipi; Linsey Nohrn; Jacob Tausiani; Bryan T Romito
Journal:  SAGE Open Med       Date:  2021-06-03

4.  Clinical effectiveness of baclofen for the treatment of alcohol dependence: a review.

Authors:  Jessica L Brennan; Jonathan G Leung; Jane P Gagliardi; Sarah K Rivelli; Andrew J Muzyk
Journal:  Clin Pharmacol       Date:  2013-07-03

5.  Off-label baclofen prescribing practices among French alcohol specialists: results of a national online survey.

Authors:  Benjamin Rolland; François Paille; Benoit Fleury; Olivier Cottencin; Amine Benyamina; Henri-Jean Aubin
Journal:  PLoS One       Date:  2014-06-02       Impact factor: 3.240

6.  Fatal collapse due to autonomic dysreflexia during manual self-evacuation of bowel in a tetraplegic patient living alone: lessons to learn.

Authors:  Subramanian Vaidyanathan; Bakul M Soni; Paul Mansour; Tun Oo
Journal:  Int Med Case Rep J       Date:  2017-11-02

Review 7.  Safety Challenges of Using High Dose Baclofen for Alcohol Use Disorder: A Focused Review.

Authors:  Benjamin Rolland; Nicolas Simon; Nicolas Franchitto
Journal:  Front Psychiatry       Date:  2018-08-22       Impact factor: 4.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.